Evidence map›Paper›PMID 35177610›Full record

ArticleNature communications2022

Chemical reversible crosslinking enables measurement of RNA 3D distances and alternative conformations in cells.

Ryan Van Damme, Kongpan Li, Minjie Zhang, Jianhui Bai, Wilson H Lee, Joseph D Yesselman, Zhipeng Lu, Willem A Velema

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Identification of RNA structures and their roles in RNA functions.Nature reviews. Molecular cell biology · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Progress in 7SK ribonucleoprotein structural biology.Frontiers in molecular biosciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ryan Van Damme *Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, 90033, USA.
Kongpan Li *Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, 90033, USA.
Minjie Zhang *Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, 90033, USA.
Jianhui BaiDepartment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, 90033, USA.
Wilson H LeeDepartment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, 90033, USA.ORCID http://orcid.org/0000-0001-5873-649X
Joseph D YesselmanDepartment of Chemistry, University of Nebraska-Lincoln, 832A Hamilton Hall, Lincoln, NE, 68588, USA.
Zhipeng LuDepartment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, 90033, USA. zhipengl@usc.edu.ORCID http://orcid.org/0000-0001-5124-7546
Willem A VelemaInstitute for Molecules and Materials, Radboud University Nijmegen, Nijmegen, The Netherlands. willem.velema@ru.nl.ORCID http://orcid.org/0000-0003-0257-2734
University of Southern California · USRadboud University Nijmegen · NLUniversity of Nebraska–Lincoln · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI William Dean Wallace · 1985 to 2026
$181.4M
USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OOKHTENS, MURAD · 1995 to 2020
$21.8M
High Throughput Determination of RNA 3D Structures and Dynamics in VivoR35GM143068 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LU, ZHIPENG · 2021 to 2025
$2.1M
Decoding the RNA Structurome: Method Development and Function Analysis.R00HG009662 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LU, ZHIPENG · 2019 to 2021
$821k
Decoding the RNA structurome: method development and function analysisK99HG009662 · NHGRI · STANFORD UNIVERSITY · PI LU, ZHIPENG · 2017 to 2018
$149k
NCI NIH HHS P30 CA014089NHGRI NIH HHS K99 HG009662NHGRI NIH HHS R00 HG009662NIDDK NIH HHS P30 DK048522NIGMS NIH HHS R35 GM143068
6 · The paper itself

Abstract

Three-dimensional (3D) structures dictate the functions of RNA molecules in a wide variety of biological processes. However, direct determination of RNA 3D structures in vivo is difficult due to their large sizes, conformational heterogeneity, and dynamics. Here we present a method, Spatial 2'-Hydroxyl Acylation Reversible Crosslinking (SHARC), which uses chemical crosslinkers of defined lengths to measure distances between nucleotides in cellular RNA. Integrating crosslinking, exonuclease (exo) trimming, proximity ligation, and high throughput sequencing, SHARC enables transcriptome-wide tertiary structure contact maps at high accuracy and precision, revealing heterogeneous RNA structures and interactions. SHARC data provide constraints that improves Rosetta-based RNA 3D structure modeling at near-nanometer resolution. Integrating SHARC-exo with other crosslinking-based methods, we discover compact folding of the 7SK RNA, a critical regulator of transcriptional elongation. These results establish a strategy for measuring RNA 3D distances and alternative conformations in their native cellular context.

Indexed as

Models, MolecularAcylationCross-Linking ReagentsHEK293 CellsHeLa CellsHumansNucleic Acid ConformationRNARNA FoldingTranscription Elongation, GeneticCross-Linking ReagentsRNA

Identifiers

PMID35177610
PMCPMC8854666
OpenAlexW4221081450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.